Morepen Laboratories Share Price
113.50-3.95 (-3.36%)
+127.14% past 1 Year
Morepen Laboratories is engaged in the manufacturing and sale of APis/ Bulk Drugs Home Diagnostics Formulations and OTC products. The plant at Masulkhana is for manufacture of Loratadine an anti-allergy
Corporate filings & documents
Announcements
Newspaper publication for completion of dispatch of the notice of 41st AGM and Annual report for the FY 2025-26
1 day agoNewspaper publication for completion of dispatch of the notice of 41st AGM and Annual report for the FY 2025-26
1 day agoPlease find attached the specimen letter
2 days agoPlease find attached the specimen letter
2 days agoPlease find attached the BRSR for the financial year ended March 31 2026
2 days agoPlease find attached the BRSR for the financial year ended March 31 2026
2 days agoPlease find enclosed notice of 41st AGM scheduled to be held on Saturday 26th September 2026 at 1:00 p.m. through VC/OAVM.
2 days agoPlease find enclosed notice of 41st AGM scheduled to be held on Saturday 26th September 2026 at 1:00 p.m. through VC/OAVM.
2 days agoPlease find attached the Annual Report for the financial year 2025-26 along with notice of 41st AGM
2 days agoPlease find attached the Annual Report for the financial year 2025-26 along with notice of 41st AGM
2 days agoNewspaper publication-information relating to 41st Annual General Meeting Dividend and record date
1 week agoNewspaper publication-information relating to 41st Annual General Meeting Dividend and record date
1 week agoAllotment of equity shares by Morepen RX Limited wholly owned subsidiary of the company
4 weeks agoAllotment of equity shares by Morepen RX Limited wholly owned subsidiary of the company
4 weeks agoNewspaper Publication Financial Results for the quarter ended June 30 2026
1 month agoNewspaper Publication Financial Results for the quarter ended June 30 2026
1 month agoPlease find attached the monitoring agency report for the quarter ended June 30 2026
1 month agoPlease find attached the monitoring agency report for the quarter ended June 30 2026
1 month ago41st Annual General Meeting scheduled to be held on September 26 2026
1 month ago41st Annual General Meeting scheduled to be held on September 26 2026
1 month agoRe-appointment of Mr. Sushil Suri as Chairman & Managing Director w.e.f. October 20 2026
1 month agoRe-appointment of Mr. Sushil Suri as Chairman & Managing Director w.e.f. October 20 2026
1 month agoPlease find attached the file
1 month agoPlease find attached the file
1 month agoPlease find attached the Press Release
1 month agoPlease find attached the Press Release
1 month agoPlease find attached the Q1 FY 27 Investor Presentation
1 month agoPlease find attached the Q1 FY 27 Investor Presentation
1 month agoPlease find attached the Q1 FY 27 Financial Results
1 month agoPlease find attached the Q1 FY 27 Financial Results
1 month agoPlease find attached the Q1 FY 27 Financial Results
1 month agoPlease find attached the Q1 FY 27 Financial Results
1 month agoMorepen Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/08/2026 inter alia to consider and approve financial results for the period ended Jun 30 2026 and other business matters
1 month agoMorepen Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/08/2026 inter alia to consider and approve financial results for the period ended Jun 30 2026 and other business matters
1 month agoThe name of wholly owned subsidiary company has been changed from Morepen Labs - FZCO to Morepen Labs FZE
1 month agoThe name of wholly owned subsidiary company has been changed from Morepen Labs - FZCO to Morepen Labs FZE
1 month agoChange in Senior Management Personnel on account of Resignation
1 month agoChange in Senior Management Personnel on account of Resignation
1 month agoPlease find enclosed the Press Release
2 months agoPlease find enclosed the Press Release
2 months agoElevation and change in designation of Mr. Sanjay Suri
2 months agoElevation and change in designation of Mr. Sanjay Suri
2 months agoclosure of trading window for DP and their immediate relatives for the quarter ended 30 June 2026
2 months agoclosure of trading window for DP and their immediate relatives for the quarter ended 30 June 2026
2 months agoPlease find enclosed the reply
2 months agoThe Exchange has sought clarification from Morepen Laboratories Ltd on June 10 2026 with reference to Movement in Volume. <BR><BR>The reply is awaited.
2 months agoThe Exchange has sought clarification from Morepen Laboratories Ltd on June 10 2026 with reference to Movement in Volume. <BR><BR>The reply is awaited.
2 months agoNewspaper Publication- Q4 and FY 26 Financial Results
3 months agoPlease find enclosed Investor Presentation on Q4 & FY26 Results
3 months agoPlease find enclosed press release
3 months agoAnnual reports
Concalls & investor presentations
Aug 2026
ConcallPresentation
May 2026
ConcallPresentation
Feb 2026
ConcallPresentation
Aug 2025
ConcallPresentation
May 2025
ConcallPresentation
May 2025
ConcallPresentation
Feb 2025
Nov 2024
ConcallPresentation
Nov 2024
ConcallPresentation
Aug 2024
ConcallPresentation
Aug 2024
ConcallPresentation
May 2024
ConcallPresentation
May 2024
ConcallPresentation
Feb 2024
ConcallPresentation
Jan 2024
ConcallPresentation
Nov 2023
ConcallPresentation
Aug 2023
ConcallPresentation
May 2023
ConcallPresentation
Feb 2023
ConcallPresentation
Nov 2022
ConcallPresentation
Jul 2022
ConcallPresentation
May 2022
ConcallPresentation
May 2022
ConcallPresentation
Feb 2022
ConcallPresentation
Feb 2022
ConcallPresentation
Nov 2021
Jul 2021
May 2021
Feb 2021
ConcallPresentation
Feb 2021
ConcallPresentation
Nov 2020
ConcallPresentation
Corporate Actions
Date
Type
Details
2026-09-18
Dividend
0.2
2025-08-29
Dividend
0.2
Company details
Registered office
Morepen Village, Malkumajra Nalagarh Road Near Baddi Solan Dist Himachal Pradesh PIN: 173205 Tel No: 01795-246401 / 02 / 03 / 244590 Fax No: 01795-244591 Email: [email protected] Internet: www.morepen.com
Registrars
T-34, 2nd Floor, Okhla Industrial Area, Phase - II, New Delhi - 110020 T-34 , 2nd Floor Okhla Industrial Area Phase - II PIN: Tel No: 011-26387281/82/83 Fax No: 011-26387384 Email: NULL Internet: www.masserv.com
Management
Sushil Suri, Chairman & Managing Director
Sushil Suri, Chairman & Managing Director
Sanjay Suri, Whole Time Director
Praveen Kumar Dutt, Non Executive Independent Director
Ranjit Khattar , Non Executive Independent Director
Sharad Jain, Non Executive Independent Director
Savita, Non Executive Independent Director
Vipul Kumar Srivastava, Company Secretary & Compliance Officer
Details
BSE 500288
NSE MOREPENLAB
ISIN INE083A01026